[18F]florbetaben

DRUG4 trials

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA), Ulsan University Hospital, Fondazione IRCCS Policlinico San Matteo di Pavia, Lantheus Germany GmbH

Conditions

AL AmyloidosisATTR AmyloidosisCardiac AmyloidosisMultiple MyelomaNormal Physiology

Early Phase 1

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

CompletedNCT02669225

National Institute on Alcohol Abuse and Alcoholism (NIAAA)Normal Physiology

Start: 2016-05-02End: 2018-07-11Updated: 2026-09-14

Phase 3

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

CompletedNCT05184088

Lantheus Germany GmbHAL Amyloidosis, ATTR Amyloidosis, Cardiac Amyloidosis

Start: 2023-01-13End: 2026-05-05Updated: 2026-08-03

Unknown Phase

Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography

CompletedNCT03779815

Ulsan University HospitalMultiple Myeloma

Start: 2018-08-20End: 2019-02-28Updated: 2019-04-18

Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis

CompletedNCT04392960

Fondazione IRCCS Policlinico San Matteo di PaviaAL Amyloidosis

Start: 2020-07-22End: 2025-06-30Updated: 2026-04-16